The American Journal of Medicine
Volume 123, Issue 1 , Pages 10-16 , January 2010

Vulnerable Plaques and Patients: Improving Prediction of Future Coronary Events

References 

  1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–e171
  2. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388–2398
  3. Virmani , Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13–C18
  4. Ambrose JA, Tannenbaum MA, Alexopoulos B, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56–62
  5. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease?. Circulation. 1988;78:1157–1166
  6. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: Insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 2000;35:106–111
  7. Brown BG, Gallery RS, Badger RS, et al. Incomplete lysis of thrombus in the moderate underlying atherosclerosis lesion during intracoronary infusion of streptokinase for acute myocardial infarction. Circulation. 1986;73:653–661
  8. Ambrose JA, Tannenbaum MA, Alexopoulos , et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56–62
  9. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Eur Heart J. 2004;25:1077–1082
  10. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83:361–366
  11. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–1363
  12. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation. 2004;110:278–284
  13. Schoenhagen P, Zinda KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndrome: an intravascular ultrasound study. Circulation. 2000;101:604–610
  14. Ambrose JA. In search of the “vulnerable plaque” (Can it be localized and will focal regional therapy ever be an option for cardiac prevention?). J Am Coll Cardiol. 2008;51:1539–1542
  15. Maseri A, Fuster V. Is there a vulnerable plaque?. Circulation. 2003;107:2068–2071
  16. Libby P. Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol. 2005;45:1600–1602
  17. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. Circulation. 2003;108:1664–1672
  18. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  19. Khot UN, Khot MB, Baizer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904
  20. Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?. J Am Coll Cardiol. 2003;41:1480–1481
  21. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart. 2006;92:1752–1759
  22. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136–148
  23. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to the cardiovascular risk assessment: the ASSIGN score form the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;2:172–176
  24. Ambrose JA, D'Agate D. Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction. Am J Cardiol. 2005;95:379–382
  25. Smith SC, Allen J, Blair SN, et al. AHA/ACC; National Heart, Lung, and Blood Institute AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung and Blood Institute. Circulation. 2006;113:2363–2372
  26. Marchioli R, Barzi F, Bomba E, et al. GISSI-Prevensione Investigators Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Dopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–1903
  27. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation. 2006;114:1549–1553
  28. Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002;347:969–974
  29. Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: Biology, epidemiology and possible therapeutic target. Arterioslcer Thromb Vasc Biol. 2005;25:923–931
  30. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129–2138
  31. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639
  32. Pearson TA, Mensah GA, Alexander RW, et al. Centers for Disease Control and Prevention: American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  33. Ridker PM, Danielson E, Fonseca FAH, et al. JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207
  34. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639
  35. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women (The Reynolds Risk Score). JAMA. 2007;297:611–619
  36. Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol. 2006;47:C57–C68
  37. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041–1046
  38. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347:1916–1923
  39. Topol EJ. The genetics of heart attack. Heart. 2006;92:855–861
  40. Topol EJ. The genomic basis of myocardial infarction. J Am Coll Cardiol. 2005;46:1456–1465
  41. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient- Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) task force report. Am J Cardiol. 2006;98(suppl):2H–15H
  42. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345
  43. Lakoske SG, Greenland P, Wong N, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham Risk Score. Arch Intern Med. 2007;167:2437–2442

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00803-1

doi: 10.1016/j.amjmed.2009.07.019

The American Journal of Medicine
Volume 123, Issue 1 , Pages 10-16 , January 2010

Article Tools

* Image Usage & Resolution